Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     
  • Bitcoin GBP

    50,494.14
    -1,034.95 (-2.01%)
     
  • CMC Crypto 200

    1,304.48
    -92.06 (-6.59%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Asia Pacific Point Of Care Diagnostics Market Forecasted to Surge, Reaching USD 15.61 Billion by 2030 with a CAGR of 8.1%

Company Logo
Company Logo

Dublin, March 06, 2024 (GLOBE NEWSWIRE) -- The "Asia Pacific Point Of Care Diagnostics Market Size, Share & Trends Analysis Report By Product (Infectious Diseases, Glucose Testing, Cardiac Markers), By End-use (Clinics, Home, Hospitals), By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

The Asia Pacific Point Of Care Diagnostics Market is poised for a substantial uptick, as a new analysis indicates the market size is set to expand rapidly, with projections estimating a market size of USD 15.61 billion by 2030, with a consistent CAGR of 8.1% from 2023 to 2030. The swell in market size is attributed to a multitude of factors including a burgeoning geriatric population, swift advancements in healthcare technology, and an escalating demand for immediate diagnostic results that bolster patient care.

Growing adoption of Point Of Care (PoC) diagnostic solutions plays a pivotal role in the decentralization of healthcare, facilitating remote medical support, contributing to the efficiency of medical diagnosis, and potentially decreasing healthcare costs. The impetus behind this market acceleration also includes facility shortages of skilled staff, prompting automation in labs and further driving the adoption of PoC products, ensuring immediate and accurate results for a variety of testing applications.

ADVERTISEMENT

Market Dynamics

  • Infectious diseases testing represents a significant share of the market, reflecting the shift to PoC diagnostics over traditional laboratory methods.

  • Cancer markers testing segments are projected to witness the fastest growth, amid rising cancer prevalence across the Asia Pacific region.

  • Clinics as end-users command a substantial portion of the market revenue, showcasing the key role they play in delivering healthcare services, especially within rural and underprivileged communities.

  • China retains a dominant position in the market, partly due to the country's vast population and the corresponding challenges related to chronic and infectious diseases.

Regional Insights

The findings illuminate China's profound impact on the regional market, with a significant revenue share driven by the nation's need to manage an expansive population alongside increased incidences of diverse health conditions.

With a focus on the Asia Pacific region and a detailed assessment of diverse segments including product type and end-use application, this latest market analysis provides invaluable insights for stakeholders in the healthcare industry, including healthcare providers, policymakers, and medical device manufacturers.

As the demand for versatile healthcare solutions and efficient patient care persists, the Asia Pacific Point Of Care Diagnostics Market is expected to thrive, charting significant progress in combating health challenges in the region through instant and reliable diagnostic care.

For comprehensive information on methodologies and data sources used in this market analysis, please visit our report in the research publications section on our website.

Key Attributes

Report Attribute

Details

No. of Pages

120

Forecast Period

2022 - 2030

Estimated Market Value (USD) in 2022

$8.17 Billion

Forecasted Market Value (USD) by 2030

$15.61 Billion

Compound Annual Growth Rate

8.1%

Regions Covered

Asia Pacific

Companies Mentioned

  • Wipro

  • ZOE Limited

  • Vocalis Health

  • DarwinAI

  • Biocogniv Inc.

  • Laipac Technology Inc.

  • Gauss Surgical, Inc.

  • Oxford Immune Algorithmics Ltd

  • F. Hoffmann-La Roche Ltd.

  • QIAGEN

  • Danaher

  • Beckman Coulter, Inc.

  • Radiometer Medical ApS

  • HemoCue AB

  • BD (Becton, Dickinson, and Company)

  • BIOMÉRIEUX

  • Abbott

  • Siemens Healthcare GmbH

  • Zoetis Services LLC

  • Abaxis

  • Instrumentation Laboratory Company

  • Nova Biomedical

  • Trividia Health, Inc.

  • Quidel Corporation

  • Trinity Biotech

  • SEKISUI Diagnostics

  • Orasure Technologies, Inc.

  • Nipro Europe Group Companies

  • Spectral Medical Inc.

Key Topics Covered

  • Methodology and Scope

    • Market Segmentation & Scope

    • Research Methodology

    • Information Procurement

    • Information or Data Analysis

    • Market Formulation & Validation

    • Model Details

    • List of Secondary Sources

    • List of Primary Sources

    • Objectives

  • Executive Summary

    • Market Outlook

    • Segment Outlook

    • Competitive Insights

  • Asia Pacific Point Of Care Diagnostics Market Variables, Trends & Scope

    • Market Lineage Outlook

    • Penetration & Growth Prospect Mapping

    • Market Dynamics

    • Point Of Care Diagnostics Market Analysis Tools

  • Asia Pacific Point Of Care Diagnostics: Product Estimates & Trend Analysis

    • Point Of Care Diagnostics Market: Key Takeaways

    • Point Of Care Diagnostics Market: Movement & Market Share Analysis

    • Glucose Testing

    • Hb1Ac Testing

    • Coagulation

    • Fertility/Pregnancy

    • Infectious Diseases

    • Cardiac Markers

    • Thyroid Stimulating Hormone

    • Hematology

    • Primary Care Systems

    • Decentralized Clinical Chemistry

    • Feces

    • Lipid Testing

    • Cancer Marker

    • Blood Gas/Electrolytes

    • Ambulatory Chemistry

    • Drug Abuse Testing

    • Autoimmune Disease

    • Urinalysis/Nephrology

  • Asia Pacific Point Of Care Diagnostics Market: End Use Estimates & Trend Analysis

    • Point Of Care Diagnostics Market: Key Takeaways

    • Point Of Care Diagnostics Market: Movement & Market Share Analysis

    • Clinics

    • Hospitals

    • Home

    • Assisted Living Healthcare Facilities

    • Laboratory

  • Asia Pacific Point Of Care Diagnostics Market: Regional Estimates & Trend Analysis

    • Regional Outlook

    • Point Of Care Diagnostics Market by Region: Key Marketplace Takeaway

    • Asia Pacific

  • Competitive Landscape

    • Recent Developments & Impact Analysis, By Key Market Participants

    • Market Participant Categorization

For more information about this report visit https://www.researchandmarkets.com/r/34hjg6

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900